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INTRODUCTION
Hypoxemia remains a challenge in the practice of gastro-
intestinal (GI) endoscopy. Insufficient ventilation caused by 
either hypoventilation or airway obstruction is the common 
underlying mechanism of hypoxemia and contributes to 
morbidity and mortality.1,2 As a result, patients are at risk for 
hemoglobin decompensation, hypoxic brain injury, dysrhyth-
mia, and death.3 Aspiration during endoscopy and colonosco-
py is another mechanism that contribute to the development 
of hypoxemia, which is potentially fatal.4,5
In the last few decades, there have advancements in the 
devices used for GI endoscopy, and the existing devices have 
been improvised, in order to reduce the risk of hypoxemia. 
The common goal is to maintain airway patency and eliminate 
dead space by providing high flow oxygen or positive pressure 
ventilation. Provision of any form of ventilation support while 
the endoscopist is performing the intervention can further 
add to the safety. Patients undergoing upper GI endoscopy are 
often sedated until apnea occurs, and the degree of sedation 
is frequently similar to that during general anesthesia. Nearly 
50% of the time, the degree of propofol-induced sedation is 
similar to that during general anesthesia or deep general anes-
thesia.6 As a result, apnea is inevitable, which further leads to 
oxygen desaturation. By appropriate preoxygenation, one can 
achieve a safe apnea time of up to 11 minutes, which is defined 
as the time it takes for pulse oximeter to register a desaturation 
to 90% despite the absence of ventilation. Apneic insufflation 
is another technique frequently employed by anesthesia pro-
viders to prolong safe apnea time. Devices that are used in 
endoscopy sedation delay desaturation and improve safety by 
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one or more of the above mechanisms.
In the following paragraphs, we aimed to discuss the indi-
vidual devices for endoscopy sedation and their merits and 
drawbacks. Particular effort is made to explain the physio-me-
chanical basis of their operation and their true clinical utility.
HIGH-FLOW NASAL CANNULA 
SUPPORTIVE OXYGEN THERAPY
This device (Fig. 1) utilizes the principle of prolonging safe 
apnea time by apneic insufflation. Its use is not new in the 
field of anesthesia and intensive care. Placement of a high-
flow nasal cannula (HFNC), initially setting the oxygen flow 
rate to 4 L/min then increasing to 15 L/min to provide apneic 
oxygenation when the patient is sedated, is known to provide 
additional time during laryngoscopy and intubation.3 De-
nitrogenation of the lungs to attain a 100% oxygen saturation 
before the administration of a sedative agent via a tight-fitting 
face mask is necessary to attain maximum benefit during the 
upper GI endoscopy.  
The appropriate administration of high-flow nasal oxygen 
is necessary to benefit from this technique. In a prospective 
randomized placebo-controlled trial involving 60 patients, 
the group who received nasal oxygen supplementation at 10 
L/min during apnea associated with laryngoscopy did not 
experience any significant prolongation of apnea desaturation 
safety periods compared with those without nasal oxygen sup-
plementation.7 The time for pulse oximeter oxygen saturation 
(SpO2) to fall from 100% to 92% (desaturation safety time) was 
also measured. The use of appropriate device to administer 
high-flow nasal oxygen is important. 
Although many devices are capable of providing high-flow 
nasal oxygen, only a few are used in GI endoscopy. Unlike 
noninvasive ventilation, HFNC reduces the dead space.8 
The HFNC system consists of an active heated humidifier, 
flow generator, single heated circuit, and nasal cannula. Such 
systems are used in critically ill patients to avoid invasive me-
chanical ventilation and after planned extubation.9 In addition 
to reducing or eliminating dead space, these high-flow systems 
are known to provide positive end-expiratory pressure effect. 
By increasing nasopharyngeal airway pressure that peaks at 
the end of expiration, they potentially decrease the work of 
breathing and enhance oxygenation in patients with alveolar 
filling diseases such as congestive heart failure or acute respi-
ratory distress syndrome. The mean nasopharyngeal pressure 
during nasal high-flow oxygen increases as flow increases.10 
Use of dry gas in these devices can lead to mucociliary mal-
function, epithelial damage, mucus plugging, ulceration of 
mucosa, and lung injury; hence, the gas should be humidified.
Use of HFNC in upper GI endoscopy is a relatively new, but 
attractive concept. AIRVO 2 (Fisher & Paykel Healthcare Lim-
ited, Auckland, New Zealand) is a system employed in patients 
undergoing both routine and advanced upper GI endoscopic 
procedures. It is a humidifier with integrated flow generator 
that provides high-flow warmed and humidified gases to 
spontaneously breathing patients through a variety of patient 
interfaces. As mentioned, this system delivers oxygen nasally 
and generates flow-dependent positive airway pressure (PAP). 
This device was recently tried in a multicenter, prospective 
randomized single-blinded study of 1,994 outpatients under-
going routine gastroscopy with propofol sedation. Compared 
with nasal oxygen administered using the same cannula at a 
rate of 2 L/min, the HFNC group (O2 [30–60 L/min] had a 
lower incidence of hypoxia (75% ≤ SpO2 <90% for <60 sec) 
and severe hypoxia (SpO2 <75% for any duration or 75% ≤ 
SpO2 <90% for ≥60 sec) from 8.4% to 0% (p<0.001) and 
from 0.6% to 0% (p=0.03), respectively.11 However, during 
this study, a number of ethical and practical issues had been 
raised. It is inconceivable that anesthesia providers allow 
severe hypoxia to develop for such durations without active 
aggressive interventions. Such interventions include increasing 
nasal oxygen flow, chin lift-jaw thrust maneuvers, and early 
endoscope withdrawal followed by face mask ventilation and 
artificial airway if necessary. Although such maneuvers were 
performed in this study, they were implemented late during 
the desaturation period. These maneuvers should be employed 
based on patients’ ventilatory efforts, well before desaturation. 
Considering the steep slope of oxyhemoglobin dissociation 
curve, employing these measures at an oxygen saturation of 
95% could be too late in the process of airway management. 
Additionally, 2 L/min of oxygen in the non-high-flow group 
is not the standard practice of anesthesia providers in North 
America. A total of 1.5 to 2.5 mg/kg of propofol is considered 
too high for a diagnostic upper endoscopy and predisposes Fig. 1. High-flow nasal cannula Optiflow.
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patients’ to hypoventilation followed by hypoxemia. It seemed 
that the investigators triggered the development of hypoven-
tilation and hypoxemia to determine whether high-flow nasal 
oxygen prevents such episodes. Consequently, it is not surpris-
ing that they could demonstrate striking differences between 
the two groups. Lastly, the average procedure duration was 
about 5 minutes. Bearing in mind that the safe apnea time 
after preoxygenation is higher than 5 minutes, the entire study 
should be called into question. 
The adverse effects of high-flow nasal oxygen use include 
rhinalgia, pharyngalgia, xeromycteria, headache, and baro-
trauma (e.g., pneumothorax and subcutaneous emphysema).
The cost of this device is another important factor. With 
falling payments for such procedures and potentially chang-
ing insurance remuneration, the cost becomes an important 
factor. In selected patients such as those with obstructive sleep 
apnea, morbid obesity, chronic obstructive airway disease 
(COPD), and pulmonary fibrosis, and those who underwent 
long, complicated advanced endoscopic procedures, HFNC 
could be useful. It can avoid the need for endotracheal intuba-
tion and reduce the risks of hypoxemia.
MODIFIED BITE BLOCKS
Goudra’s bite block
The two primary mechanisms of HFNC are to administer 
100% oxygen and provide some degree of positive end expira-
tory pressure in the pharynx. The same concept is employed 
in Goudra’s bite block (Fig. 2). Although the device is still not 
marketed, the functionality is worthy of further discussion.  
Anatomically, unlike many devices available in the market, 
this bite block incorporates the elements of a face mask and 
airway into the endoscopy bite block. The idea is to provide 
100% oxygen at the laryngeal inlet with the likelihood of some 
degree of continuous PAP (CPAP) due to the high concentra-
tion of oxygen flowing into the pharyngeal area. It also reduces 
the anatomical dead space. The oxygen can leak only into the 
atmosphere through the mouth, which is often sealed, and 
nose, which is generally open. The device is connected to a 
Mapleson breathing system. By occluding all avenues of air 
leak aside from adjusting the pressure-limiting valve, it is pos-
sible to provide some degree of positive pressure ventilation. 
At the time of writing, the device is still not available in the 
market. 
Oxygen providing bite blocks
Respa oxygen delivery bite block (Fig. 3) is the latest ad-
dition to the Endoscopy’s family of bite blocks in the United 
States.12 It was built to hold the nasal cannula in place during 
procedures. Anyone practicing sedation for upper GI endos-
copy would have observed the practical difficulties in both 
placing and more importantly retaining the oxygen cannula. 
No studies have documented its effectiveness and possible ad-
verse effects. The OxyShieldTM (Fig. 4) is another endoscopic 
bite block with similar capabilities.13 By providing constant 
Fig. 2. Goudra’s bite block.
Fig. 3. Respa O2 delivery bite block.
Fig. 4. OxyShieldTM.
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guaranteed supplemental oxygen, these devices can reduce the 
incidence of hypoxemia without dramatic adaption or change 
in the practice.
FACE MASKS
Procedural Oxygen Mask® 
Procedural Oxygen Mask® (POM®) (https://proceduralox-
ygenmask.com/) (Fig. 5) improves oxygenation by increasing 
the oxygen concentration at the laryngeal inlet. It is similar 
to the non-rebreathing face mask commonly used in the 
hospitals except that it has a dedicated self-sealing central ap-
erture through which the endoscopist inserts the endoscope.14 
In addition, it has an opening that accepts the standard gas 
sampling tubing female connector and thereby allows moni-
toring of the end tidal carbon dioxide. At the Hospital of the 
University of Pennsylvania, an improvisation of the standard 
rebreathing mask allows to achieve the same objective at a 
fraction of the cost (Fig. 6). 
Endoscopy face mask
One of the great challenges of providing adequate oxy-
genation in patients undergoing upper GI endoscopy is the 
inability to provide any degree of positive pressure ventilation. 
Manufacturers have tried to address this by reconfiguring the 
simple face mask by introducing an intubation port in addi-
tion to the ventilation port. An optional carbon dioxide sam-
pling port is available in some of these modifications. The face 
mask is secured with a series of hooks and harnesses. Both GI 
endoscopy and bronchoscopy including fibrotic endotracheal 
intubation can be achieved with these devices.  
Apart from being cumbersome, they are impractical to use. 
Although its use could be straightforward in patients with easy 
airway, those with airway problems such as patients with ob-
structive sleep apnea pose challenges. Unfortunately, these pa-
tients are prone to hypoventilation and hypoxemia. Examples 
of these endoscopy masks are DEAS endoscopic mask15 and 
VBM Endoscopy Mask (Figs. 7, 8).16
Endoscopic nasal mask
Endoscopic nasal mask is a multifunctional device designed 
to provide oxygen via positive pressure, if necessary. As can be 
deciphered from the photos, it has a respiratory interface with 
a soft cushion, a nasal aperture, and a flexible connector, all as-
sembled with a breathing system. Clearly, they are complicated 
devices that require the anesthesia provider’s patience and 
dedication to succeed. 
In a randomized controlled trial, Gedeon et al. evaluated 
one such device (Fig. 9A).17 In this study, 56 patients with a 
body mass index of 40−60 were randomized into the treat-
ment, nasal mask capable of providing intermittent positive 
pressure ventilation (IPPV), and control, nasal cannula, nasal 
intermittent positive pressure ventilation (NIPPV) for rescue 
groups (n=28 treatment and n=28 control).17 Oxygen desat-
uration events were defined as less than 94% and those  events 
less than 90% required intervention. In addition, any need for 
NIPPV as a rescue maneuver was also documented. A statisti-
cally significant difference was observed in desaturation events 
Fig. 5. Procedural Oxygen Mask® (POM®). Fig. 6. Improvised nonbreathing face mask.
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Fig. 7. DEAS endoscopic mask.
Fig. 8. VBM Endoscopy Mask.
Fig. 9. (A) Endoscopic nasal mask (Arilite), (B) SuperNO2VA nasal positive airway pressure (PAP) ventilation system, (C) SuperNO2VA nasal PAP ventilation 




Goudra B et al. Devices for GI Endoscopy Sedation
between groups, and those with NIPPV have a lower risk of 
desaturation. In fact, every patient in the control group devel-
oped desaturation necessitating NIPPV for rescue purposes. 
Similar to the HFNC study mentioned above,11 the authors did 
not actively intervene until the SpO2 was less than or equal to 
94%, which is unacceptable in clinical practice. In fact, the first 
rescue maneuver was initiated if the SpO2 was less than 90%, 
which might be considered negligent especially in morbidly 
obese patients. However, the authors concluded that an ad-
junct, noninvasive positive pressure ventilation (using bilevel 
PAP) results in decreased incidence of desaturation events in 
severely obese patients undergoing upper GI endoscopy. The 
type and description of the device used to provide NIPPV is 
not provided by the authors. The following pressure settings 
were used: inspiratory PAP of 12-cm H2O and expiratory PAP 
of 6-cm H2O with FiO2 1.00. The pressure was adjusted by 1- 
to 2-cm H2O to achieve a tidal volume of 450 to 500 mL, up 
to a maximum inspiratory PAP of 18-cm H2O and expiratory 
PAP of 8-cm H2O.
A second device, also providing nasal IPPV, is the Super-
NO2VA nasal PAP ventilation system made by CareFusion 
(Fig. 9B-D). This device has been investigated in at least two 
studies, one involving colonoscopy and the other involving 
upper GI endoscopy. The device looks similar to a pediatric 
face mask. Instead of an inflatable seal, it has a self-sealing rig-
id cushion that can potentially cause trauma, especially when 
used long term. Compression of both nasolacrimal duct and 
eyes is a distinct possibility. Additionally, it has some design 
flaws. The oxygen flowing into the mask can create a Venturi 
effect and prevent the reservoir bag from filling with oxygen. 
As a result, positive pressure ventilation will be impossible 
and higher flows will further deplete the bag. In Fig. 9B, flows 
of 30 L/min have failed to inflate the bag. In spite of these de-
sign drawbacks, the mask is found to reduce the frequency of 
hypoxemia during upper GI endoscopy in patients planning 
to undergo bariatric surgery.18 Many of these patients had ob-
structive sleep apnea. However, the intervention in the control 
group was not comparable as they were given conventional 
nasal cannula oxygen. Similarly, the SuperNO2VATM nasal 
oxygen mask at a target CPAP of 10 cm H2O improved venti-
lation and decreased the frequency and severity of hypoxemia 
in spontaneously breathing obese patients during colonosco-
py.19 The device’s mechanism of protection against hypoxemia 
is similar to that of several devices employed in GI endoscopy. 
It provides 100% oxygen, some degree of CPAP, increases safe 
apnea time, and allows some degree of apneic insufflation. In 
Fig. 9C and D, to eliminate the Venturi effect depleting the 
bag, the connections are modified to allow oxygen flow into 
the bag instead of the nose. The heat moisture exchanger port 
also permits monitoring of end tidal carbon dioxide. 
AIRWAY DEVICES
Nasopharyngeal airway
A simple flexible nasopharyngeal airway used appropriately 
is the best insurance against hypoventilation-associated hy-
poxemia. At the Hospital of the University of Pennsylvania, we 
have extensive experience in the use of this technique in thou-
sands of patients for more than a decade. The modification 
is elegantly demonstrated in the picture (Figs. 10-12). After 
adequate preoxygenation, we administered appropriate dose 
of propofol, typically preceded with a small dose of fentanyl 
especially in patients undergoing advanced endoscopic pro-
cedures. If the appropriate depth of anesthesia is achieved, an 
appropriate-sized nasopharyngeal airway is inserted into the 
predetermined side without applying undue pressure. Some of 
our colleagues pretreat the nose with a vasoconstrictive agent, 
but this is not necessary. More importantly, anesthesia pro-
viders must be cognizant of the force used during insertion. If 
resistance is high, the second nostril should be used. Generous 
lubrication is necessary to obtain a high degree of success and 
safety. 
Fig. 10. Assembly of nasopharyngeal airway with an endotracheal tube 
connector, bag, and Mapelson breathing system assembly.
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The nasopharyngeal airway should be attached to an endo-
tracheal tube (ET) connector prior to insertion. A 28−30-Fr 
tube (attached to the 8.0 ET tube connector) should be used in 
adult women and a 32−34-Fr tube in adult men (connected to 
a 9.0 ET tube connector). After insertion, the ET tube connec-
tor of the nasopharyngeal airway is connected to a Mapleson 
breathing system as demonstrated in the photo. An oxygen 
flow of 8−12 liters with an open expiratory valve is provided. If 
necessary, the oxygen inflow can be increased to 30−35 liters. 
It is important to observe the bag all the time. If the distal end 
of the tube is obstructed or the proximal end of the nasopha-
ryngeal airway is kinked, the bag will expand, sometimes dan-
gerously. 
This modification serves many purposes that are performed 
by expensive modern devices. It provides high concentra-
tion of oxygen at the laryngeal inlet. It also provides CPAP, 
especially if the oral exit is not fully open. Even with an open 
oral exit, depending on oxygen flow rate, a degree of positive 
pressure will be noticeable as can be appreciated by the shape 
of the breathing bag. A combination of apneic insufflation and 
positive pressure can delay the hypoxemia despite the presence 
of hypoventilation. Patients typically start self-ventilating after 
insertion of the endoscope, and appropriate depth of anes-
thesia is maintained from this point. It is possible to provide a 
small degree of positive pressure ventilation, especially if the 
second naris is closed and a hand is applied around the endo-
scope to close the mouth. Fresh gas flows should be increased 
appropriately to compensate for the loss of gas due to leakage. 
At the Hospital of the University of Pennsylvania, we have 
enormous success with this technique in a variety of patients 
scheduled to undergo various procedures including an array 
of advanced procedures.20-22 
Wei nasal jet tube
This device (Fig. 13) looks like a standard nasopharyngeal 
airway except that it has two smaller additional channels 
embedded into the wall with their own external outlets. One 
of these channels is for insertion of a jet ventilation catheter, 
while the other is meant for gas sampling for monitoring end 
tidal carbon dioxide. In a multicenter clinical trial, Qin et al. 
found that the use of supraglottic jet ventilation via Wei nasal 
jet tube reduced the incidence of hypoxia in patients who were 
sedated with propofol during upper GI endoscopy proce-
dures.23 A total of 1,781 patients were studied in the time peri-
od, from March 2015 to July 2016. Of them, one-third received 
supraglottic jet ventilation, another one-third were adminis-
tered with oxygen via the nasal tube, and the remaining one-
third were administered with oxygen via nasal cannula. Use of 
Fig. 11. Nasopharyngeal assembly demonstrated in Fig. 9. and used in an 
obese patient with severe sleep apnea.
Fig. 12. End-tidal carbon dioxide tracing of the patient in Fig. 11.
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Wei nasal tube was associated with a reduction in hypoxemia 
irrespective of the use of supraglottic jet ventilation. Even in 
this subgroup, the incidence of hypoxia reduced from 9% to 
3% (p<0.0001) in the jet ventilation group compared with the 
Wei tube without jet ventilation group.23
The use of supraglottic jet ventilation is considered unnec-
essary in most upper GI endoscopic procedures. However, 
it can be used in patients undergoing advanced procedures. 
The technique is not free of side effects. There was an increase 
incidence of ventilation-related minor adverse events 1 min 
after the procedure, which eventually decreased 30 min later. 
At best, the technique could be described as experimental and 
might be safe in the hands of enthusiasts. Jet ventilation can 
also be administered with a standard nasopharyngeal airway. 
Gastro-Laryngeal Tube
The Gastro-Laryngeal Tube (G-LT, VBM Medizintechnik 
GmbH, Sulz, Germany; Fig. 14)24 is a modified laryngeal 
tube placed in the supraglottic space. It is designed to obtain 
and retain control of airway patency during GI endoscopic 
procedures under deep sedation or general anesthesia while 
maintaining spontaneous or assisted ventilation. Similar to 
LMA®GastroTM Airway, it has a dedicated channel where the 
endoscope can be inserted. A preliminary study by Gaitini et 
al. evaluated the effectiveness of airway management with a 
G-LT and the possibility of performing procedures using the 
endoscopic channel.25 They found that the G-LT is an effective 
and safe device for patients undergoing endoscopic retrograde 
cholangiopancreatography (ERCP).25 However, in a case series 
involving 22 patients undergoing interventional endoscopic 
biliopancreatic procedures, Fabbri reported the occurrence of 
sore throat in two patients after the procedure, asymptomatic 
erosion of the upper esophageal mucosa in two patients, Mal-
lory−Weiss syndrome in one patient, and pancreatitis after 
ERCP in one patient.26 By any standard of care, this finding 
suggest the extremely high incidence of device-related compli-
cations. The increased risk of complications can be attributed 
to size and complexity of the device. The necessity of general 
anesthesia is another drawback. However, Davis et al. observed 
a significantly lesser degree of stress response in comparison 
to endotracheal intubation in patients undergoing ERCP.27
The majority of ERCPs in North America are performed 
under deep sedation without any additional airway or relative-
ly less invasive airways.20,28 As a result, the administration of 
general anesthesia with all its attendant complications to facili-
tate the insertion of G-LT seemed to be excessive. 
LMA®GastroTM
LMA®GastroTM Airway (Teleflex Medical, Athlone, Ireland; 
Fig. 15) is a dual channel airway whose method of insertion 
and removal is similar to that of a standard laryngeal mask air-
way. As a result, deep general anesthesia is required to facilitate 
its insertion. In addition to the standard channel to provide 
pulmonary ventilation, the device has a second channel be-
hind it that allows insertion of a gastroscope. It is supposed to 
provide esophageal intubation while providing an unobstruct-
ed airway and positive pressure lung ventilation with clinically 
satisfactory seal pressures.29
In the first human, open label, prospective, observational study 
of the device, Terblanche et al. reported that LMA®GastroTM 
Airway is safe and effective.29 The study included American 
Society of Anesthesiology (ASA) physical status classification 1 
and 2 patients at low risk of pulmonary aspiration undergoing 
upper GI endoscopy. The sedation protocol involved 2–3 mg 
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Table 1. Comparison of Airway Devices Employed in Gastrointestinal Endoscopy
Device Principle of action Advantages/benefits  Limitations 
High-flow nasal cannula support-
ive oxygen therapy
Creation of CPAP
Administration of 100% oxygen
Prolongation of apnea time
Apneic insufflation of oxygen
Decreased incidence of oxygen 
desaturation 
Ability to increase CPAP by 




galgia, headache, and barotrauma
Goudra’s bite block Creation of CPAP
Administration of 100% oxygen
Prolongation of apnea time
Apneic insufflation of oxygen
Decreased desaturation
Incorporation of airway into the 
bite block
Connection to the Mapleson 
breathing systems
Ability to provide IPPV
Yet to be made available for com-
mercial use 
Procedural Oxygen Mask® 
(POM®) 
Administration of near 100% 
oxygen
Prolongation of safe apnea time
Low risk of droplet transmission
Does not provide CPAP
Cost
Endoscopy face mask 
(DEAS endoscopic mask and 
VBM Endoscopy Mask)
A facemask with a provision for 
introduction of an upper gastro-
intestinal endoscope
Allows IPPV and CPAP




Endoscopic nasal mask 
(e.g., SuperNO2VA nasal PAP 
ventilation)
Allows IPPV during the perfor-
mance of the procedure
Decreased incidence of desatura-
tion
The self-sealing rigid cushion 
can potentially cause trauma, 
especially when used long term
Nasopharyngeal airway Creation of CPAP
Administration of 100% oxygen
Prolongation of apnea time
Apneic insufflation of oxygen
Allows IPPV to a limited extent
Easily available, the assembly of 
nasal airway and the  Mapleson 
breathing systems can be easily 
mastered and implemented
Nasal bleed, occasional difficulty 
in the insertion of nasopharyn-
geal airway
Wei nasal jet tube A special triple lumen nasal 
airway that allows jet ventila-
tion, connection to a Mapleson 
breathing system and sampling 
of respiratory gas
Decreased incidence of desatura-
tion
Cost and cumbersome to use; 
nasal bleeding
Gastro-Laryngeal Tube A modified laryngeal tube placed 
in the supraglottic space; has a 
dedicated channel for the inser-
tion of an endoscope
Reduced incidence of oxygen 
desaturation
Requires GA for insertion; higher 
stress response and trauma
LMA®GastroTM Dual-channel laryngeal mask 
airway
Has a separate channel for intro-
duction of endoscope including 
larger scopes for ERCP and 
endoscopic ultrasound
Reduced incidence of oxygen 
desaturation
Requires GA for insertion; higher 
stress response and trauma
CPAP, continuous positive airway pressure; ERCP, endoscopic retrograde cholangiopancreatography; GA, general anesthesia; IPPV, inter-
mittent positive pressure ventilation.
kg−1 IV propofol. Premedication (0.03 mg kg−1 midazolam, 
1–2 μg kg−1 fentanyl, and 5–10 μg kg−1 alfentanil) was allowed. 
Sufficient propofol to maintain general anesthesia was ad-
ministered during the entire procedure. Clearly, the depth of 
anesthesia required needed to be sufficient for the insertion of 
LMA®GastroTM Airway. The dedicated endoscopy channel has 
an internal diameter of 16 mm, which might be sufficient for 
insertion of most gastroscopes. The outer diameters of even 
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dual channel and therapeutic gastroscopes are significantly 
smaller than 16 mm.30 The majority of the procedures per-
formed in this study were diagnostic upper GI endoscopy with 
or without colonoscopy. 
CONCLUSIONS
Apart from LMA®GastroTM Airway and G-LT, all devices, 
improvised or not, rely in their ability to increase oxygen 
concentrations at the laryngeal inlet to nearly 100% and/or 
provide a degree of positive end expiratory pressure. Depen-
dence on apneic insufflation and increased safe apnea time are 
the major aspects of their functioning. The majority of upper 
GI endoscopies are diagnostic and do not last more than 5−10 
minutes. Some of the ERCP procedures such as removal of 
stents are quickly performed. As a result, LMA®GastroTM Air-
way, which necessarily requires the administration of general 
anesthesia, to facilitate insertion and retention, would be con-
sidered excessive. Similarly, the use of HFNC are prohibited 
in the majority of patients except those prone to rapid desat-
uration. Examples include patients with COPD, pulmonary 
fibrosis, and morbid obesity. However, general anesthesia with 
endotracheal intubation might be safer and more appropriate 
in such patients. There are two devices that can provide posi-
tive pressure ventilation. While Wei nasal airway relies on jet 
ventilation, Goudra’s bite block requires establishing a proper 
seal to accomplish this.
In the end, caution should still be observed. Providing safe 
sedation for endoscopy is both an art and science. An under-
standing of the pulmonary physiology and careful evaluation 
of the patient’s airway are essential. A low threshold, especially 
in patients scheduled for advanced endoscopic procedures, is 
beneficial during intubation. The majority of patients who de-
veloped cardiac arrests and died after undergoing endoscopy 
are due hypoventilation and hypoxemia. Having a core group 
of anesthesia providers will go a long way in increasing the 
safety.31 
It is not possible to describe every device that is available or 
invented. However, an effort is made to provide the pros and 
cons of using some of these devices. Table 1 provides a com-
parison of the airway devices employed in GI endoscopy.
Conflicts of Interest  
Basavana Goudra is director of endoscopy anesthesia services at the Penn 
Presbyterian Medical Center; FDA member for Anesthetic and Analgesic 







Preet Mohinder Singh: https://orcid.org/0000-0001-7642-529X
REFERENCES
1. Goudra B, Nuzat A, Singh PM, Gouda GB, Carlin A, Manjunath AK. 
Cardiac arrests in patients undergoing gastrointestinal endoscopy: 
a retrospective analysis of 73,029 procedures. Saudi J Gastroenterol 
2015;21:400-411.
2. Goudra B, Nuzat A, Singh PM, Borle A, Carlin A, Gouda G. Association 
between type of sedation and the adverse events associated with gastro-
intestinal endoscopy: an analysis of 5 years’ data from a tertiary center in 
the USA. Clin Endosc 2017;50:161-169.
3. Gleason JM, Christian BR, Barton ED. Nasal cannula apneic oxygen-
ation prevents desaturation during endotracheal intubation: an integra-
tive literature review. West J Emerg Med 2018;19:403-411.
4. Bielawska B, Hookey LC, Sutradhar R, et al. Anesthesia assistance in 
outpatient colonoscopy and risk of aspiration pneumonia, bowel perfo-
ration, and splenic injury. Gastroenterology 2018;154:77-85.e3.
5. Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks associated with 
anesthesia services during colonoscopy. Gastroenterology 2016;150:888-
894; quiz e18.
6. Goudra B, Singh PM, Gouda G, Borle A, Carlin A, Yadwad A. Propofol 
and non-propofol based sedation for outpatient colonoscopy-prospec-
tive comparison of depth of sedation using an EEG based SEDLine 
monitor. J Clin Monit Comput 2016;30:551-557.
7. Sahay N, Sharma S, Bhadani UK, Sinha C, Kumar A, Ranjan A. Effect of 
nasal oxygen supplementation during apnoea of intubation on arterial 
oxygen levels: a prospective randomised controlled trial. Indian J An-
aesth 2017;61:897-902.
8. Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir 
Care 2019;64:735-742.
9. Zhu Y, Yin H, Zhang R, Ye X, Wei J. High-flow nasal cannula oxygen 
therapy versus conventional oxygen therapy in patients after planned ex-
tubation: a systematic review and meta-analysis. Crit Care 2019;23:180.
10. Parke RL, Eccleston ML, McGuinness SP. The effects of flow on air-
way pressure during nasal high-flow oxygen therapy. Respir Care 
2011;56:1151-1155.
11. Lin Y, Zhang X, Li L, et al. High-flow nasal cannula oxygen therapy and 
hypoxia during gastroscopy with propofol sedation: a randomized mul-
ticenter clinical trial. Gastrointest Endosc 2019;90:591-601.
12. Respa O2 Delivery Bite Block [Internet]. Mentor (OH): STERIS; c2019 
[cited 2019 Sep 14]. Available from: https://www.steris.com/healthcare/
products/endoscopy-devices/gi-procedure-products/bite-blocks/respa-
o2-bite-block.
13. Using OxyshieldTM [Internet]. Achenmühle: OxyshieldTM; c2019 [cited 
2019 Sep 14]. Available from: http://www.oxy-shield.com/UsingOx-
yshield.
14. Procedural Oxygen Mask [Internet]. Simi Valley (CA): POM Medical; 
c2019 [cited 2019 Sep 13]. Available from: https://proceduraloxygen-
mask.com/.
15. Endoscopic Mask [Internet]. Castel Bolognese: DEAS; c2019 [cited 2019 
Sep 13]. Available from: https://www.deasnet.it/product-catalogue/air-
way-management/endoscopic-mask/.
16. Endoscopy Mask, Bronchoscope Airway [Internet]. Einsteinstrasse: 
VBM Medizintechnik GmbH; c2019 [cited 2019 Sep 13]. Available 
from: https://www.vbm-medical.com/products/airway-management/
endoscopy-mask/.
17. Gedeon M, Gomes S, Roy K, Duclos-Miller P, Rose JS. Use of nonin-
vasive positive pressure ventilation in patients with severe obesity un-
192
dergoing esophagogastroduodenoscopy: a randomized controlled trial. 
Surg Obes Relat Dis 2019;15:1589-1594.
18. Dimou F, Huynh S, Dakin G, et al. Nasal positive pressure with the 
SuperNO2VA
TM device decreases sedation-related hypoxemia during 
pre-bariatric surgery EGD. Surg Endosc 2019;33:3828-3832.
19. Bai Y, Xu Z, Chandrashekar M, et al. Comparison of a simplified nasal 
continuous positive airways pressure device with nasal cannula in obese 
patients undergoing colonoscopy during deep sedation: a randomised 
clinical trial. Eur J Anaesthesiol 2019;36:633-640.
20. Goudra BG, Singh PM, Sinha AC. Outpatient endoscopic retrograde 
cholangiopancreatography: safety and efficacy of anesthetic manage-
ment with a natural airway in 653 consecutive procedures. Saudi J An-
aesth 2013;7:259-265.
21. Goudra BG, Singh PM, Penugonda LC, Speck RM, Sinha AC. Signifi-
cantly reduced hypoxemic events in morbidly obese patients undergoing 
gastrointestinal endoscopy: predictors and practice effect. J Anaesthesiol 
Clin Pharmacol 2014;30:71-77.
22. Goudra BG, Penugonda LC, Sinha A. A novel way of anesthetizing and 
maintaining airway/ventilation in an ultra-morbidly obese patient pre-
senting for upper GI endoscopy. J Clin Anesth 2012;24:604-605.
23. Qin Y, Li LZ, Zhang XQ, et al. Supraglottic jet oxygenation and ventila-
tion enhances oxygenation during upper gastrointestinal endoscopy in 
patients sedated with propofol: a randomized multicentre clinical trial. 
Br J Anaesth 2017;119:158-166.
24. Gastro-Laryngeal Tube (G-LT) [Internet]. Einsteinstrasse: VBM Mediz-
intechnik GmbH; c2019 [cited 2019 Sep 13]. Available from: http://
carestreammedical.com/wp-content/uploads/Carestream-VBM-Gas-
tro-Laryngeal-Tubes.pdf.
25. Gaitini LA, Lavi A, Stermer E, Charco Mora P, Pott LM, Vaida SJ. Gas-
tro-laryngeal tube for endoscopic retrograde cholangiopancreatography: 
a preliminary report. Anaesthesia 2010;65:1114-1118.
26. Fabbri C, Luigiano C, Cennamo V, et al. The Gastro-laryngeal tube for 
interventional endoscopic biliopancreatic procedures in anesthetized 
patients. Endoscopy 2012;44:1051-1054.
27. Davis J, Sreevastava DK, Dwivedi D, Gadgi S, Sud S, Dudeja P. A com-
parison of stress response between insertion of gastro-laryngeal tube 
and endotracheal intubation in patients undergoing upper gastrointesti-
nal endoscopic procedures for endoscopic retrograde cholangiopancrea-
tography. Anesth Essays Res 2019;13:13-18.
28. Barnett SR, Berzin T, Sanaka S, Pleskow D, Sawhney M, Chuttani R. 
Deep sedation without intubation for ERCP is appropriate in healthier, 
non-obese patients. Dig Dis Sci 2013;58:3287-3292.
29. Terblanche NCS, Middleton C, Choi-Lundberg DL, Skinner M. Efficacy 
of a new dual channel laryngeal mask airway, the LMA®GastroTM Air-
way, for upper gastrointestinal endoscopy: a prospective observational 
study. Br J Anaesth 2018;120:353-360.
30. ELUXEO® 700 Series Gastroscopes [Internet]. Valhalla (NY): Fujifilm 
USA; c2019 [cited 2019 Sep 11]. Available from: https://www.fujifilmu-
sa.com/products/medical/endoscopy/endoscopes/gastroscopes/index.
html#dualChannel.
31. Goudra BG, Singh PM, Sinha AC. Anesthesia for ERCP: impact of an-
esthesiologist’s experience on outcome and cost. Anesthesiol Res Pract 
2013;2013:570518.
